Recombinant Human GLP2R Protein (HEK293)，His

Glucagon-like peptide-2 receptor (GLP2R) is a critical component of the gastrointestinal system, primarily involved in regulating intestinal growth, enhancing nutrient absorption, and promoting gut health. Research on GLP2R is particularly relevant due to its potential therapeutic applications in conditions such as short bowel syndrome, inflammatory bowel disease, and other gastrointestinal disorders. The receptor is activated by the hormone glucagon-like peptide-2 (GLP-2), which is secreted in response to food intake and plays a vital role in stimulating the growth and repair of the intestinal mucosa. Recombinant proteins of GLP2R are utilized in various studies to understand the signaling pathways and biological functions of the receptor more comprehensively. The development of these proteins is pivotal for screening potential drug candidates and understanding receptor structure-function relationships. Additionally, investigating GLP2R interactions at the molecular level could facilitate the design of new therapeutic agents that leverage this pathway, offering novel treatments for patients suffering from debilitating gastrointestinal conditions. Overall, GLP2R research, especially involving recombinant protein studies, holds significant promise for advancing gastrointestinal medicine and improving patient outcomes.